News and events archive

The "Domore!" project presented by national newspaper VG

Håvard Danielsen (photo: Hallgeir Vågenes, VG)

The "DoMore!" project headed by Håvard E. Danielsen, director of the Institute for Cancer Genetics and Informatics, was recently presented in a feature article in the major national Norwegian newspaper VG.

By examining 20.000 cancer tumor samples from more than 7000 patients and using artificial intelligence the scientists look for patterns that may say something about a patient's prognosis. They focus on the three most common forms of cancer - lung, colorectal and prostate cancer. Results from the project har recently been published in Lancet Oncology (journal impact factor 36.4).

The DoMore! project was selected in 2016 as one of the Norwegian Research Council’s Lighthouse projects to solve large societal challenges using cutting-edge technologym and will run until 2021.

Dag Berild "Researcher of the Month" for July 2018

Dag Berili (photo: Elin B. Øvrebø)

Dag Berild, head of the "Study group for rational antibiotic use" at the Department of Infectious Diseases at the Division of Medicine was appointed "Researcher of the Month" for July 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF).

Antibiotic resistance is now one of the biggest threats to public health in the world. Dag Berild was among the first to warn against the wrong use of antibiotics.
Berild's research activities is presented in a feature article published on the home page of Helse Sør-Øst.

 

Postdoctor Andreas M. Hoff is shared first-authorNew publication in Cell on structural genome alterations driving castration-resistant prostate cancer

Andreas M. Hoff

Postdoctor Andreas M. Hoff in the Skotheim group at the Department of Molecular Oncology spent a year of his postdoc in the lab of Matthew Meyerson at the Broad Institute and Dana Farber Cancer Institute, Boston, USA. As shared first-author, he publishes together with his colleagues at the Meyerson lab in the prestigous journal Cell (impact factor 30).

The University of Oslo Research Award 2018 til Harald Stenmark

Harald Stenmark (photo: Terje Heiestad, Uio)

Professor Harald A. Stenmark, head of the "Cellular membrane dynamics" research group at the Department of Molecular Cell Biology at the Institute for Cancer Research, has been given the prestigious University of Oslo Research Research Award for 2018.

In their statement the prize committee wishes to acknowledge one of the University's most prominent researchers in cancer research and cell biology, who has built an internationally renowned research environment that delivers innovative and original research helping to put the University of Oslo on the world map.

The research award will be distributed during the annual UiO party on September 2nd. Prizes for education, communication and innovation will also be given out during this event, each of the four awards amounting to 250.000 NOK.

Announcement of research funding from South-East Norway regional health authority for 2019

The South-Eastern Norway Regional Health Authority hereby announces a call for applications for research projects and research activities starting in 2019.

The total funding available for this call is approximately 100 million Norwegian kroner.

Application deadline is Tuesday, September 5th 2018 kl. 16:00.

Therese Seierstad "Researcher of the Month" for June 2018

Therese Seierstad

Therese Seierstad from Mona-Elisabeth Revheim's "Functional and Molecular Imaging" research group at the Division of Radiology and Nuclear Medicine was appointed "Researcher of the Month" for June 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). Her research is mostly focused on prostate cancer and breast cancer. As head of research at the division she is also involved in research projects not directly related to cancer treatment.
Seierstad's work is presented in a feature article published on the home page of Helse Sør-Øst.

EMBO Journal article from Malerød and Haglund: Orienting the spindle

From left: Andreas Brech, Kaisa Haglund (last author), Lene Malerød (first author), Harald Stenmark, Anette Lie-Jensen and Åsmund Husabø Eikenes

An article by senior scientist Lene Malerød and her co-workers in Kaisa Haglund’s project group shows how the mitotic spindle achieves its correct orientation during cell division.

The article ”Centrosomal ALIX regulates mitotic spindle orientation by modulating astral microtubule dynamics” was published online on June 1 in The EMBO Journal and elucidates a previously unrecognized biological role of the multifunctional adaptor protein ALIX during cell division. Specifically, ALIX is recruited to centrosomes, where it promotes correct mitotic spindle orientation at metaphase during both asymmetric and symmetric cell division, by facilitating the formation of astral microtubules.

The 2018 Oslo University Hospital Research Awards to Klungland, Haugaa and Westlye

From left: Last T. Westlye, Arne Klungland and Kristin H. Haugaa.

Three scientists received awards for their outstanding research at a ceremony taking place at Oslo University Hospital June 8th.

The major prize - the "Excellent Researcher Award" - went to professor Arne Klungland.

Kristina H. Haugaa and Lars Tjelta Westlye both received the "Early Career Award".

The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities. This prize is distributed anually in order to honour excellent scientific work.

Project headed by Ilangko Balasingham placed on the Horizon 2020 Innovation Radar

Ali Khaleghi (left) and Ilangko Balasingham

WiBEC (Wireless In-Body Environment Communications) is a Horizon 2020 Marie Skłodowska-Curie Innovative Training Network and trains 16 young researchers in coordinated manner by academia, industry and medical centres. WiBEC is led by Professor Ilangko Balasingham at the Intervention Centre at Oslo University Hospital.

WiBEC has been identified by the Innovation Radar - a European Commission initiative to identify high potential innovations and innovators in EU-funded research and innovation framework programmes. 

WiBEC’s main objective is to provide high quality and innovative doctoral training to develop the wireless technologies for novel implantable devices that will contribute to the improvement in quality and efficacy of healthcare. These are innovations that are actively exploring value creation opportunities and rated by the European Commission as Excellent Science.

 

Questionable use of beta blockers in heart attack treatment:BETAMI trial funded by Klinbeforsk

Dan Atar

The BETAMI trial - "BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function" - has been funded with 15 mill NOK from Klinbeforsk - the national "Clinical therapy research in the specialist health services" program. The trial is led by Dan Atar, head of research at the Division of Medicine and leader of the "Ischemic Heart Disease" group.
In the 80's and 90's it was considered important to administer beta blockers to avoid future cardiac deaths and new heart attacks. "But huge progress has been made, among other things, the blockage of blood vessels is very effective. We do not know if beta-blocking is still necessary", says Atar, who has recently been interviewed by "Dagens Medisin".

Support from Horizon 2020 to 16 projects headed by Oslo University Hospital

Kristian Berg, head of the "Lumiblast" project, giving prominent guests a tour of his lab (from RCN news article).

The Research Council of Norway reports that Norway exceeds two per cent share of Horizon 2020 contribution for the first time.  Figures from the EU show a steady increase in the number of Norwegian projects with successful proposals. “It would appear that Norwegian applicants have cracked the code and that we’re now surging ahead,” states John-Arne Røttingen, Chief Executive of the Research Council.
Of the more than 10 mill Euro going to Norwegian health authorities Oslo University Hospital receive 7.9 mill Euro and Helse Bergen 1.6 mill Euro.

Paper from Selbo’s project group featured on the cover of Photochemical & Photobiological Sciences

The paper entitled “Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins” by Marius S. Eng et al. was a joint academic-industry effort including collaboration with the Ferronel lab at Massachusetts General Hospital/Harvard Medical School, the Rosenblum lab at MD Anderson Cancer Center, the Mælandsmo lab at Oslo University Hospital (OUS), the Imaging Facility at the Institute for Cancer Research (OUS) and PCI Biotech. The manuscript was published in the May issue of Photochemical & Photobiological Sciences (The Royal Society of Chemistry), which is a society-owned journal publishing high quality research on all aspects of photochemistry and photobiology.

Award ceremony May 25thOslo University Hospital awards 6 excellent articles for the second half-year of 2017

From the award ceremony May 25th

In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly.

Six research groups were awarded for their excellent papers published during the second half-year of 2017 on May 25th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.

Gut bacteria flora linked to chronic heart failure

Martin Kummen (left) and Marius Trøseid

Findings from scientists at the Research Institute of Internal Medicine published in the prestigious "Journal of the American College of Cardiology" (journal impact factor 19.9) has received attention.  Martin Kummen and Marius Trøseid are first and last authors on the publication, entitled "Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts".

The Norwegian popular science web site "forskning.no" has recently written about the results, and interviewed senior author Marius Trøseid about the linking of gut bacteria flora to chronic heart failure.

Theodossiou and Berg presented in national media after receiving prestigious EU grant

Berg and Theodossiou with Prime Minister Erna Solberg and Minister of Research and Higher Education Iselin Nybø. Photo: Hallgeir Vågenes/ VG

Theodossis Theodossiou and Kristian Berg from the Photochemical internalisation (PCI) group at the Department of Radiation Biology at the Institute for Cancer Research have been funded by the Future and Emerging Technology (FET) program under the Excellent Science section of the Horizon 2020. The FET program funded 11 projects out of 820 grant applications (1,4 % success rate) and the proposal by Theodossiou and Berg was rated as number 6. The  project is designed to develop treatment of aggressive brain tumors such as glioblastoma multiforme (GBM).
The major national newspaper VG recently (May 3rd) published a feature article about the supported project, entitled "Pioneering Norwegian technology: aiming to kill aggressive brain tumors by producing light in the brain."

Oslo Myeloma Center in the media

Fredrik Schjesvold has recently been interviewed for NRK's "Ekko".

Fredrik Schjesvold, leader of the "Oslo Myeloma Center" research group at the Department of Haematology at Oslo University Hospital, has recently been interviewed by the national broadcasting corporation NRK for the the popular radio programme "Ekko", under the column "Meet a researcher". Schjesvold has also been interviewed for an international multiple myeloma podcast. Furthermore, a video presenting the Oslo Myeloma Center has been produced.

OUS research blog article:Treating rare bleeding disease with cancer medicine

Johan Steineger (left) and Sinan Dheyauldeen

In a recent OUS research blog article Johan Steineger and Sinan Dheyauldeen from the Department for Otorhinolaryngology, Head and Neck Surgery explain how they came to treating patients with Morbus Osler - a rare autosomal dominant disorder that affects blood vessels throughout the body (causing vascular dysplasia) and results in a tendency for bleeding. - with the anti-angiogenic medicine Avastin, which is often used with chemotherapy to prevent tumor growth.

Espen Melum "Researcher of the Month"

Espen Melum

Espen Melum, head of the "Experimental Hepatology" group at the Research Institute of Internal Medicine, under the Division of Surgery, Inflammatory Diseases and Transplantation, was appointed "Researcher of the Month" for March 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF).
Melum's research group studies why inflammation occurs in the bile ducts, which in turn can lead to liver failure. His work is presented in a feature article published on the home page of Helse Sør-Øst.

OUH research seminar, Monday, April 16th, 2018, at 14:30 – 16:00Precision medicine in complex diseases

Welcome to the next Oslo University Hospital (OUH) research seminar entitled
Precision medicine in complex diseases

Time: Monday, April 16th, 2018, at 14:30 – 16:00
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo

Speakers: Yvonne Böttcher, Hanne Flinstad Harbo, Torbjørn Omland, Kåre I. Birkeland, Rune A. Høglund.

 

European Research Council Advanced Grant to Stenmark for the second time

Professor Harald Stenmark. Foto: Øystein Horgmo, UiO

Professor Harald Stenmark, head of the "Cellular membrane dynamics" group at the Department of Molecular Cell Biology, receives ERC Advanced Grant for the second time. Only two other Norwegian researchers, Professor Edvard Moser (NTNU) and Professor Kenneth Hugdahl (UiB), have received ERC Advanced Grant twice in their careers.

The research project "Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics (CODE)" will last for five years and has been awarded 2.5 million Euro.

Previous news articles
 On the occasion of King Olav V's award to Professor Vessela N. Kristensen Mini symposium Cancer Genomics, April 17th, 10am-4pm 
 Cancer study led by OUH scientists presented by major national newspaper VG  
 Novel subtype-specific prognostic associations of KRAS and BRAF mutations revealed in colorectal cancer  
 Prestigious neurological award to David Russell  
 Jon Amund Kyte "Researcher of the Month"  
 The Challenges women face in pursuing a career in STEM (science/ technology/ engineering/ mathematics) International Women's day, March 8th 2018: 
 King Olav V´s Cancer Research Prize for 2018 to Vessela Kristensen Updated: 
 Tissue engineering and regenerative medicine OUH research seminar, Monday, March 5th, 2018, at 14:30 – 16:00 
 A human endothelial cell-based recycling assay for screening of FcRn targeted molecules Nature Communications publication: 
 Kyrre Emblem among the three research talents honoured by the Norwegian Research Council  
 Ole Jacob Elle appointed "Innovator of the Month" by "Helse Sør-Øst"  
 Substantial grant from HELSEVEL to Jon Michael Gran  
 Leiv Arne Rosseland "Researcher of the Month" for January 2018  
 Interdepartmental collaboration cuts drug costs on expensive antibodies for treating eye diseases  
 Prestigious grant to Tor Erik Rusten  
 New developments in gynecologic oncology OUH research seminar, Monday, February 5th, 2018, at 14:30 – 16:00 
 Karl-Johan Malmberg interviewed by NRK on the potential of killer cell research in cancer treatment  
 Therese Sørlie appointed "Scientist of the Month" by "Helse Sør-Øst"  
 Rusten group research project on cell organisation and tumor growth highlighted by the Norwegian Cancer Society  
 Excellent Researcher Award and Early Career Award 2018 Nominating outstanding scientists, closing date March 1st: 
 Genetics of cardiovascular diseases OUH research seminar, Monday, January 15th, 2018, at 14:30 – 16:00 
 Tillotts Pharma AG signs license agreement on antibody technology developed by OUS and UiO scientists Press release Jan 22, 2018
 Cell therapy research presented in national newspaper VG  
 Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer  
 The discovery of TIGIT as a potential new target for immune checkpoint blockade is published in Clinical Cancer Research.  
 Scientists from the Research Institute of Internal Medicine receive funding from ERA-Net  
 Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2017  
 Per Steinar Halvorsen appointed "Innovator of the Month" by Helse Sør-Øst  
 The challenges of discovering new antibiotics OUH research seminar, Monday, December 4th 14:30 
 The Laboratory of Adaptive Immunity and Homeostasis enters a strategic research collaboration with a leading pharmaceutical company Press release – 29 Nov 2017 
 Alicia Llorente participates in an ERA-NET funded project  
 Young Investigator Prize to Anita Sveen during annual "Onkologisk Forum" meeting Nov 2017  
 Michael Bretthauer appointed "Scientist of the Month" by "Helse Sør-Øst"  
 Paper on novel pathway selected for inclusion in the ‘In This Issue’ section of Journal of Cell Science  
 Jan Terje Andersen receives a grant of 8.5 million NOK from NANO2021  
 Professor Kjetil Taskén is presented as new director of the Department of Cancer Research at the Cancer Clinic, Oslo University Hospital  
 Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors Nature Communications publication: 
 A study of the epigenetics of breast cancer provides clues to mechanisms behind subtypes of the disease Nature Communications publication: 
 Maria Torgersen receives a grant of 8.5 million NOK from NANO2021  
 Inequality in genetic cancer risk: Bad genes or bad luck? Nature Communications article from OCBE: 
 Rusten group uncovers new regulatory mechanism of the Peutz-Jeghers cancer syndrome kinase, LKB1 Update: Nature Cell Biology paper attracts interest: 
 Major study of genetics of breast cancer provides clues to mechanisms behind the disease CNN coverage: 
 Albumedix has signed research agreement with OUS and UiO on CIR research  
 CCB researchers uncover novel mechanism of cellular metabolic control  
 New additional treatment for breast cancer patients Breast cancer research highlighted by the Norwegian Cancer Society: 
 Individualized cancer treatment OUH research seminar, Monday, October 9th 14:30 
 Induced pluripotent stem cell research featured on Norwegian national news broadcast  
 Tor Inge Tønnessen "Researcher of the Month" for September  
 Collaboration to identify novel biomarkers that can predict whether a patient will respond positively to pembrolizumab  
 Scientific opportunities in Europe Sept 29th - Information day about EMBL, EMBO and HSPF: 
 Jahre lecture Thursday September 14th  
 The Norwegian Cancer symposium 2017 on Precision Medicine Scandic Holmenkollen Park, December 4-6, 2017: 
 Anne-Lise Børresen-Dale appointed Commander of the Royal Norwegian St. Olavs Order  
 ERC Starting Grant 2017 to Kyrre Eeg Emblem  
 Tone Rustøen "Researcher of the Month" for July  
 Håvard Danielsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2017  
 OUH scientists involved in sequencing study of osteosarcoma that has identified mutations in IGF signalling genes  
 Øyvind S. Bruland appointed "Innovator of the Month" by Helse Sør-Øst  
 Lars Tjelta Westlye appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2017  
  Announcement of research funding from South-East Norway regional health authority for 2018 Call for applications 2018 
 Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2016  
 Clinically important genetic heterogeneity in colorectal cancers with microsatellite instability  
 Per O. Seglen awarded King Olav V's cancer research prize for 2017  
 New mechanism for rare skin disorder discovered  
 Norwegian research with international impact Less expensive medicine results in treatment for more patients 
 The 2017 Excellent Research Awards to Kirsten Sandvig, Johannes Espolin Roksund Hov and Tor Paaske Utheim  
 Organ donation for abdominal and thoracic organs OUH research seminar, Monday, May 8th 14:30 - 16:00 
 Placing my research in an H2020 project Program Info - workshops held May 8-9th: 
 New insight into late effects after cancer treatment presented by the Norwegian Cancer Society  
 Immunotherapy for Cancer OUH research seminar, Tuesday, April 25th 10:00 - 15:45 
 Study on replication fork stability from Skarstad group published in Nucleic Acids Research  
 Innovation to Finance Research OUH research seminar, Monday, April 3rd 14:30 
 NORMENT researchers contribute to PLOS Medicine article on genetic assessment of age-associated Alzheimer's disease risk  
 The AACR-WICR Friend Lectureship presented to Anne-Lise Børresen-Dale  
 CanCell – a new Centre of Excellence – will reprogram cancer cells  
 Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology New group leader at the Institute for Cancer Research: 
 Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research King Olav V´s Cancer Research Prize to Per O. Seglen Mar 7, 2017
 Health after transplantation OUH research seminar, Monday, March 6th 14:30 
 Early signs of mental illness in the developing brain NORMENT study published in Nature Neuroscience: 
 Arne Klungland talks about embryo research Breakfast lecture in Oslo Wednesday March 1st: 
 Thon Awards seminars 2017 Invitation to seminar March 2nd 12:00 
 Critical article on doping and drug testing published in EMBO reports  
 Early phase drug development: From idea to concept OUH research seminar, Monday, February 6th 14:30 
 "Science" article from Johanna Olweus's group highlighted by editorial in New England Journal of Medicine  
 6th National Conference on Stroke Oslo Kongressenter, February 09-10 2017 
 Theis Tønnessen appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2017  
 Sepsis: New definitions and future research OUH research seminar, Thursday, January 26th 
 Excellent Researcher Award and Early Career Award 2017 Announcement: Nominating outstanding scientists, closing date March 1st: 
 Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma? OUH research seminar, Monday, January 16th 
 Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention Updated: honoured with "Preview" article in Developmental Cell  
 Commentary article from Arne Klungland in Nature Methods on epitranscriptome analysis  
 Research funding from South-Eastern Norway Regional Health Authority for 2017  
 Educating future cancer researchers from Ullern high school  
 Novel cancer immunotherapy published in Cancer Research, with cover illustration  
 Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2016  
 Oslo University Hospital research seminar: Exercise and Brain Energy Monday, November 21st, 2016, at 14:30 – 16:10 
 Oslo University Hospital research seminar: The World of Immunology Thursday November 17th at 10:00-15:00 
 Oslo University Hospital researchers receive 77.3 mill NOK from the Norwegian Cancer Society Results of Open Call 2016: 
 Human lung macrophages are self-maintained for several years  
 Announcement of research funding from the Norwegian Cancer Society Gathering Friday October 28th 10-12 at UiO: